comparemela.com

Latest Breaking News On - Naureen quibria - Page 1 : comparemela.com

GlycoMimetics, Inc (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United statesTara bancroftChristian dinneenBruce johnsonBrian hahnHarout semerjianNaureen quibriaChildren oncology group phaseCompany counsel at glycomimeticsGlycomimetics incPediatric early phase clinical trial networkDana farber cancer instituteAmerican cancer societyNational cancer instituteAlliance for clinical trials in oncologyAmerican society of hematology research collaborative

Chimerix, Inc (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix Third Quarter 2023 Earnings Conference Call.

United statesBritish columbiaJosh allenMike andrioleNaureen quibriaMaury raycroftMichelle laspalutoAllen melemedEuropean association for neuroConference in cancer researchCapital oneSociety for neuroOncology communityChimerix incCall transcript novemberChimerix third quarter

ADC Therapeutics SA (NYSE:ADCT) Q2 2023 Earnings Call Transcript

Operator: Hello, and welcome to the ADC Therapeutics Second Quarter 2023 Financial Results Conference Call. My name is Corey, and I ll be your operator for today s call.

United statesNew yorkMohamed zakiGregory renzaBrian chanEugenia litzMorgan stanleyNaureen quibriaKelly shiKristen herrington smithPepe carmonaAdc telecommunications inc old filingsCorporate communicationsMd anderson cancer centerCall transcript augustSecond quarter

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Q1 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals First Quarter 2023 Earnings and Corporate Update Conference Call.

Rosti raykovRostislav raykovNaureen quibriaRaghuram selvarajuDavid nierengartenRobert andradeEuropean commissionEuropean unionMedicaid servicesExchange commissionFennec pharmaceuticals incUs centers of medicareFennec pharmaceuticals first quarterFennec pharmaceuticalsNational comprehensive cancer networkChildren oncology group

Chimerix, Inc (NASDAQ:CMRX) Q1 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix First Quarter 2023 Earnings Conference Call.

United statesMike shermanMaury raycroftCarl koschmannRed whiteAllen melemedNaureen quibriaJosh allenTroy langfordMike andrioleMichelle laspalutoAmerican association for cancer research annual meetingUniversity of michiganChimerix incBrown universityEuropean union

vimarsana © 2020. All Rights Reserved.